The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Sassine Andy since year 2005.
The trader's CIK number is 1515322.
At the time of this reporting, Sassine Andy is the Director of Gemphire Therapeutics Inc. .
(stock ticker symbol GEMP).
See this page for all insider trading activities at Gemphire Therapeutics Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-03-10||GEMP||Gemphire Therapeutics Inc.||Buy||21,119||9.47||199,996|
|2014-06-05||ACFN||Data Systems & Software Inc||Buy||20,607||1.68||34,516|
|2014-06-04||ACFN||Data Systems & Software Inc||Buy||212,077||1.71||362,863|
|2013-12-02||ACFN||Data Systems & Software Inc||Buy||12,724||3.57||45,462|
|2013-11-27||ACFN||Data Systems & Software Inc||Buy||22,158||3.71||82,095|
|2013-10-18||ACFN||Data Systems & Software Inc||Buy||6,988||3.25||22,711|
|2013-08-12||CNSO||Cns Response, Inc.||Option Ex||3,498,200||.25||874,550|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sassine Andy (Director of Gemphire Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.